Cardiovascular complications arising from COVID-19 are known to contribute significantly to mortality rates. The COVIRNA project is a patient-centred Innovation Action focused on developing an innovative diagnostic test that can improve individualised surveillance, care and follow-up of COVID-19 patients by identifying those who are at risk of developing fatal cardiovascular complications. Detecting risks before patients even start having symptoms will enable to reduce the burden of disease by improving therapeutic approaches and informing novel drug design. On a wider scale, the COVIRNA project also aims to improve the cooperation between European research institutions to strengthen the response to the COVID-19 pandemic.  

This session will examine the benefits of personalised disease management on health systems and discuss how patient-centred care and personalised medicine can improve disease outcome and enhance patients’ quality of life. Personalised disease management and personalised medicine move away from a one-size-fits-all solution in favour of an approach that recognises the genomic and clinical specificities of each individual patient, and the different forms complex diseases can take. Treatments and care planning can therefore be tailored and adapted to patients to ultimately improve their health outcomes by making treatments more effective and with fewer side effects.    

This session will also cover additional questions that a crucial to consider when moving towards personalised medicine. For instance, while the use personalised medicine often relies on data, multiple challenges arise when it comes to sharing data across health institutions. This session will discuss potential ways in which these challenges can be addressed. Furthermore, AI and machine learning have proven to be powerful tools in health and this session will highlight how we can employ them to develop predictive models. Lastly, the session will explore how we can bring innovations, such as the COVIRNA tool, to the end-users, namely the patients. 

To learn more about the COVIRNA project, its goals and objectives, you can visit the website and you can join the session on Wednesday, 15 September 2021 at 13.30 at EHMA 2021. 

Join EHMA 2021, the preeminent European conference on health management, meet with experts from Europe and beyond, and be part of shaping the future of health management.